🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Using multiple techniques the authors affirm that Gfral expression is overwhelmingly restricted to the brainstem in healthy mice Molecular Metabolism Centre universitaire de santé McGill Randy J. Seeley, Ph.D. sciencedirect.com/science/articl…

Are you a bioinformatician looking for an opportunity to work Inst Metabolic Science-Metabolic Research Labs Cambridge University? We are looking to expand our core team, and are looking for a Team Leader! Please contact me for more info, please share, deadline Dec 15, 2024 jobs.cam.ac.uk/job/49233/

Very happy to have this paper out with my long standing collaborators at University of Michigan #seeleyrj and Martin G Myers

Exploring the neurobiology of the most important adipose-brain signal #leptin with the most important gut-brain signal #GLP1. Novo Nordisk and Uni Michigan collaboration for many years. Randy J. Seeley, Ph.D. science.org/doi/10.1126/sc…

An excellent example of industry-academia collaboration! Thanks to Lotte Bjerre Knudsen and Novo Nordisk.

A few minutes of me on this podcast discussing our latest work on a GLP-1/leptin co-agonist.

We are now accepting applications for the nhlbi funded SURP program in UMPhysiology. If you are an undergrad looking for a summer research experience in the areas of cardiovascular disease, lung disease, or sleep research, check it out! medschool.umich.edu/departments/mo…

New studies in mice revealing distinct roles for prolactin-related peptide and its receptors in control of food intake Molecular Metabolism Randy J. Seeley, Ph.D. University of Michigan sciencedirect.com/science/articl…

The scientist who is responsible for driving GLP-1 drugs for the treatment of obesity and testing them for prevention of Alzheimer's disease—Lotte Bjerre Knudsen— tells her story in a remarkable conversation. Full transcript, or video, all free, no ads. Link in my profile,

Don’t miss out! Randy Seeley, PhD, will be giving a talk this Friday about pharmacologic treatment of obesity, hosted by Monika Burness, MD, and Melissa Pilewskie, MD. Location: Med Sci II, North Lecture Hall

Why does Randy J. Seeley, Ph.D. get so many questions about GLP-1 drugs like Ozempic? Who better to explain than the researcher himself? Here he discusses his research dissecting bariatric surgery and how that work has contributed to the development of these drugs. michmed.org/Myjnk

I wrote up an FAQ about the recent federal grant cuts. A few key points 🧵:

Sometimes vaccine efficacy is subtle Sometimes it isn't

Answers to a few questions from Nina Teicholz, PhD about incidences of censorship I recently experienced at NIH: 1. My request was denied by HHS to present an invited keynote talk on my ultra-processed food (UPF) research at the Bloomberg Philanthropies annual Food Policy Program

The Multidisciplinary Training Program in Basic Diabetes Research T32 at Michigan Medicine is accepting applications from postdoctoral fellows interested in diabetes and metabolic disease research. Deadline May 16. Apply and learn more here: medschool.umich.edu/departments/in…

#DDW2025 #Obesity #therapeutics and #mechanisms!

Great overview of the world of peptides by STAT featuring Randy J. Seeley, Ph.D.. statnews.com/2025/05/08/pep…

Peptides: The solution to all your health problems? Influencers and direct-to-consumer health platforms think so. Our own Randy J. Seeley, Ph.D. weighed in with STAT about the recent peptide craze, and he's very dubious about the safety of the internet market. michmed.org/kVVKZ

Will I see you at #Nutrition2025 in Orlando? Looking forward to presenting insights Tuesday on the far-reaching effects of new #ObesityMedicines. Join me, Gary Foster, PhD, Randy J. Seeley, Ph.D., and Leah Whigham for a fascinating session. Digital pass available, too. nutrition2025.eventscribe.net/index.asp?sess…